Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease

BACKGROUND: Cannabis benefits patients with inflammatory bowel disease (IBD). Cannabinoid receptors are expressed in gut immune cells and in epithelial cells of inflamed guts. Mucosal healing (MH) requires epithelial layer restoration. OBJECTIVE: To analyze the effects of CB2 agonist on parameters i...

Full description

Saved in:
Bibliographic Details
Published in:United European Gastroenterol J
Main Authors: Tartakover Matalon, Shelly, Ringel, Yehuda, Konikoff, Fred, Drucker, Liat, Pery, Shaul, Naftali, Timna
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7184658/
https://ncbi.nlm.nih.gov/pubmed/32213014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619889773
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items